This finding is in concordance with a previous quantitative proteomics study in which ApoA was found to be increased after anti-TB drug treatment in cured versus untreated tuberculosis patients44, thus strongly indicating that rifampicin/isoniazid treatment increases the serum levels of this protein. The gene discussed is APOA1; the disease is tuberculosis.